These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
438 related articles for article (PubMed ID: 29223804)
1. Oxindole based oxadiazole hybrid analogs: Novel α-glucosidase inhibitors. Taha M; Imran S; Rahim F; Wadood A; Khan KM Bioorg Chem; 2018 Feb; 76():273-280. PubMed ID: 29223804 [TBL] [Abstract][Full Text] [Related]
2. Synthesis, molecular docking and α-glucosidase inhibition of 5-aryl-2-(6'-nitrobenzofuran-2'-yl)-1,3,4-oxadiazoles. Taha M; Ismail NH; Imran S; Wadood A; Rahim F; Saad SM; Khan KM; Nasir A Bioorg Chem; 2016 Jun; 66():117-23. PubMed ID: 27149363 [TBL] [Abstract][Full Text] [Related]
3. A new entry into the portfolio of α-glucosidase inhibitors as potent therapeutics for type 2 diabetes: Design, bioevaluation and one-pot multi-component synthesis of diamine-bridged coumarinyl oxadiazole conjugates. Kazmi M; Zaib S; Ibrar A; Amjad ST; Shafique Z; Mehsud S; Saeed A; Iqbal J; Khan I Bioorg Chem; 2018 Apr; 77():190-202. PubMed ID: 29421697 [TBL] [Abstract][Full Text] [Related]
4. Synthesis, In vitro α-Glucosidase Inhibitory Potential and Molecular Docking Studies of 2-Amino-1,3,4-Oxadiazole Derivatives. Ullah H; Rahim F; Taha M; Hussain R; Wadood A; Nawaz M; Wahab Z; Kanwal ; Khan KM Med Chem; 2020; 16(6):724-734. PubMed ID: 31195948 [TBL] [Abstract][Full Text] [Related]
5. Synthesis of benzothiazole derivatives as a potent α-glucosidase inhibitor. Gollapalli M; Taha M; Javid MT; Almandil NB; Rahim F; Wadood A; Mosaddik A; Ibrahim M; Alqahtani MA; Bamarouf YA Bioorg Chem; 2019 Apr; 85():33-48. PubMed ID: 30599411 [TBL] [Abstract][Full Text] [Related]
6. Synthesis, α-glucosidase inhibitory activity and in silico study of tris-indole hybrid scaffold with oxadiazole ring: As potential leads for the management of type-II diabetes mellitus. Taha M; Rahim F; Imran S; Ismail NH; Ullah H; Selvaraj M; Javid MT; Salar U; Ali M; Khan KM Bioorg Chem; 2017 Oct; 74():30-40. PubMed ID: 28750203 [TBL] [Abstract][Full Text] [Related]
7. Synthesis of Bis-indolylmethane sulfonohydrazides derivatives as potent α-Glucosidase inhibitors. Gollapalli M; Taha M; Ullah H; Nawaz M; AlMuqarrabun LMR; Rahim F; Qureshi F; Mosaddik A; Ahmat N; Khan KM Bioorg Chem; 2018 Oct; 80():112-120. PubMed ID: 29894890 [TBL] [Abstract][Full Text] [Related]
9. New indole based hybrid oxadiazole scaffolds with N-substituted acetamides: As potent anti-diabetic agents. Nazir M; Abbasi MA; Aziz-Ur-Rehman ; Siddiqui SZ; Khan KM; Kanwal ; Salar U; Shahid M; Ashraf M; Arif Lodhi M; Ali Khan F Bioorg Chem; 2018 Dec; 81():253-263. PubMed ID: 30153590 [TBL] [Abstract][Full Text] [Related]
10. Synthesis of tetracyclic oxindoles and evaluation of their α-glucosidase inhibitory and glucose consumption-promoting activity. Hao L; Ma Y; Zhao L; Zhang Y; Zhang X; Ma Y; Dodd RH; Sun H; Yu P Bioorg Med Chem Lett; 2020 Jul; 30(14):127264. PubMed ID: 32527562 [TBL] [Abstract][Full Text] [Related]
11. Inhibitory activity evaluation and mechanistic studies of tetracyclic oxindole derivatives as α-glucosidase inhibitors. Sun H; Zhang Y; Ding W; Zhao X; Song X; Wang D; Li Y; Han K; Yang Y; Ma Y; Wang R; Wang D; Yu P Eur J Med Chem; 2016 Nov; 123():365-378. PubMed ID: 27487567 [TBL] [Abstract][Full Text] [Related]
12. Design, synthesis and in vitro study of densely functionalized oxindoles as potent α-glucosidase inhibitors. Luthra T; Naga Lalitha K; Agarwal R; Uma A; Sen S Bioorg Med Chem; 2018 Oct; 26(18):4996-5005. PubMed ID: 30153956 [TBL] [Abstract][Full Text] [Related]
14. Synthesis, in vitro α-glucosidase inhibitory potential and molecular docking study of thiadiazole analogs. Javid MT; Rahim F; Taha M; Rehman HU; Nawaz M; Wadood A; Imran S; Uddin I; Mosaddik A; Khan KM Bioorg Chem; 2018 Aug; 78():201-209. PubMed ID: 29597114 [TBL] [Abstract][Full Text] [Related]
15. Design, synthesis and docking study of novel tetracyclic oxindole derivatives as α-glucosidase inhibitors. Han K; Li Y; Zhang Y; Teng Y; Ma Y; Wang M; Wang R; Xu W; Yao Q; Zhang Y; Qin H; Sun H; Yu P Bioorg Med Chem Lett; 2015 Apr; 25(7):1471-5. PubMed ID: 25759031 [TBL] [Abstract][Full Text] [Related]
16. Synthesis, in vitro evaluation and molecular docking studies of biscoumarin thiourea as a new inhibitor of α-glucosidases. Zawawi NK; Taha M; Ahmat N; Ismail NH; Wadood A; Rahim F; Rehman AU Bioorg Chem; 2015 Dec; 63():36-44. PubMed ID: 26432614 [TBL] [Abstract][Full Text] [Related]
17. Synthesis of Novel Triazinoindole-Based Thiourea Hybrid: A Study on α-Glucosidase Inhibitors and Their Molecular Docking. Taha M; Alshamrani FJ; Rahim F; Hayat S; Ullah H; Zaman K; Imran S; Khan KM; Naz F Molecules; 2019 Oct; 24(21):. PubMed ID: 31652777 [TBL] [Abstract][Full Text] [Related]
18. Synthesis, α-glucosidase inhibition and molecular docking study of coumarin based derivatives. Taha M; Shah SAA; Afifi M; Imran S; Sultan S; Rahim F; Khan KM Bioorg Chem; 2018 Apr; 77():586-592. PubMed ID: 29477126 [TBL] [Abstract][Full Text] [Related]
19. Synthesis, Biological Evaluation and Molecular Docking Study of 2-Substituted-4,6-Diarylpyrimidines as α-Glucosidase Inhibitors. Gong Z; Xie Z; Qiu J; Wang G Molecules; 2017 Oct; 22(11):. PubMed ID: 29084182 [TBL] [Abstract][Full Text] [Related]
20. 2-Arylquinazolin-4(3H)-ones: A new class of α-glucosidase inhibitors. Javaid K; Saad SM; Rasheed S; Moin ST; Syed N; Fatima I; Salar U; Khan KM; Perveen S; Choudhary MI Bioorg Med Chem; 2015 Dec; 23(23):7417-21. PubMed ID: 26552899 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]